The Health Sciences Authority (HSA) introduced the Health Products Act (HPA) in 2007 to consolidate and streamline the regulatory controls of health products under one single Act. Under the streamlining process, pharmaceutical products, commonly known as chemical or biologic drugs, will be regulated as “therapeutic products” in the HPA. Thereafter, the existing controls under the Medicines Act (MA) and Poisons Act (PA) are no longer applicable to pharmaceutical products.
As one of six pieces of legislation introduced in the HPA for the regulation of therapeutic products, the Health Products (Advertisement of Therapeutic Products) Regulations 2016 has been introduced and took effect on 1 November 2016.
More information on the Health Products (Advertisement of Therapeutic Products) Regulations 2016 can be found here: http://www.hsa.gov.sg/content/hsa/en/Health_Products_Regulation/therapeutic-productsportover.html.